(Q40362937)

19 September 2017

title

A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus (English)

1 reference

19 September 2017

0 references

1 reference

1 reference

Newcastle disease virus

object named as

Newcastle disease virus

1 reference

Shin-Hee Kim

1

1 reference

19 September 2017

Anandan Paldurai

series ordinal

2

1 reference

19 September 2017

Siba K Samal

series ordinal

3

1 reference

19 September 2017

language of work or name

English

0 references

publication date

19 January 2017

1 reference

19 September 2017

1 reference

19 September 2017

volume

503

1 reference

19 September 2017

page(s)

31-36

1 reference

Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Retracted: Replication, Neurotropism, and Pathogenicity of Avian Paramyxovirus Serotypes 1-9 in Chickens and Ducks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Role of fusion protein cleavage site in the virulence of Newcastle disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Influence of insertion site of the avian influenza virus haemagglutinin (HA) gene within the Newcastle disease virus genome on HA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Practical aspects of vaccination of poultry against avian influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Complete sequence of the genome of avian paramyxovirus type 2 (strain Yucaipa) and comparison with other paramyxoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Evaluation of avian paramyxovirus serotypes 2 to 10 as vaccine vectors in chickens previously immunized against Newcastle disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Prevalence of antibodies to different avian paramyxoviruses in commercial poultry in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

P and M gene junction is the optimal insertion site in Newcastle disease virus vaccine vector for foreign gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2017.01.006

10.1016/J.VIROL.2017.01.006

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference